Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Can Nephrocheck™ Predict the Reversibility of Early, Acute Kidney Injury During Septic Shock?

NCT: NCT02812784 · COMPLETED

NCT IDNCT02812784
StatusCOMPLETED
Start Date2015-09-16
Completion2019-02-11
SponsorCentre Hospitalier Universitaire, Amiens (OTHER)
First posted
Last updated

Brief Summary

Patients with septic shock in the intensive care unit have an elevated risk of developing acute kidney injury (AKI).

Frequently Asked Questions

What is Can Nephrocheck™ Predict the Reversibility of Early, Acute Kidney Injury During Septic Shock??

Can Nephrocheck™ Predict the Reversibility of Early, Acute Kidney Injury During Septic Shock? is a clinical trial registered under NCT02812784. Current status: COMPLETED.

What is the status of NCT02812784?

The current status of NCT02812784 (Can Nephrocheck™ Predict the Reversibility of Early, Acute Kidney Injury During Septic Shock?) is: COMPLETED.

When did Can Nephrocheck™ Predict the Reversibility of Early, Acute Kidney Injury During Septic Shock? start?

Can Nephrocheck™ Predict the Reversibility of Early, Acute Kidney Injury During Septic Shock? started on 2015-09-16.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑